HomeAI · summaries
Storia in 3 fonti
Generic semaglutide widens access, but doctors warn of misuse and quality risks
Generic semaglutide increases accessibility, but doctors caution against misuse and quality concerns
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindu.com
Generic semaglutide widens access, but doctors warn of misuse and quality risks
Generic semaglutide increases accessibility, but doctors caution against misuse and quality concerns
- ·
Telangana DCA cautions against unsupervised semaglutide use amid rising drug demand for weight loss
Telangana DCA warns against unsupervised semaglutide use, stressing the importance of medical supervision and safe purchasing practices.
- ·
arabnews.com
India warns of misuse risk from cheap weight-loss jabs
India’s health ministry warned Tuesday of the risks of unregulated use of weight-loss drugs, as low-cost generic versions hit the market, stepping up inspections and enforcement…
- ·
forbes.com
Indian Pharma Billionaires Pile Into Generic Weight-Loss Drugs, Sparking Regulatory Scrutiny
Last week’s expiry of the patent for semaglutide—the active ingredient in Novo Nordisk’s blockbuster drugs Wegovy and Ozmepic that are used to treat both diabetes and…